The prevalence of type 2 diabetes and obesity continues to escalate globally, fuelling intensive research into the underlying metabolic dysregulation and innovative therapeutic strategies. Advances in ...

Across the Arabian Peninsula, home to the Gulf Cooperation Council (GCC) states, societies have transformed within a century ...

This article is authored by Swati Kanodia, consultant pediatric endocrinologist, Madhukar Rainbow Children's Hospital.

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor ...

Please provide your email address to receive an email when new articles are posted on . Some amino and fatty acid dysregulations in late pregnancy were associated with type 2 diabetes risk.

Novo Nordisk (NYSE: NVO) has entered into a collaboration and licensing agreement with U.S.-based biotech firm Septerna (NASDAQ: SEPN) to co-develop oral small molecule therapies targeting obesity, ...

In a landmark 14-year study, researchers have found that artificially sweetened drinks raise the risk of developing type 2 diabetes by more than a third, significantly higher than those loaded with ...

Elevated levels of per- and polyfluoroalkyl substances (PFAS), also known as “forever chemicals,” may be associated with metabolic disruptions potentially leading to type 2 diabetes. The presence of ...

Diabetes affects every part of the body, causing symptoms like fatigue, weight gain, mood changes, and neuropathic pain, among others. These symptoms are not unique to diabetes: They are also common ...

Obesity and type 2 diabetes are closely linked. Excess body fat can alter your body’s metabolic system, promote insulin resistance, and trigger inflammatory responses that affect how well your body ...